Harbour Biomed gives Hong Kong new IPO dose

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Harbour Biomed gives Hong Kong new IPO dose

Jonathan Breen
November 30, 2020 05:00 AM
Biotech_Adobe_575x375_Oct21
Female scientist researching samples in laboratory | Stevica Mrdja/Microgen - stock.adobe.com

China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC SecuritiesCredit SuisseEquity IPOsHealth and BiotechEquityChinaBank of AmericaChina International Capital CorpHong Kong SARAsiaGreater ChinaHaitong SecuritiesMorgan StanleyNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article